DR. REDDY S LABORATORIES vs MANKIND PHARMA LIMITED
A side-by-side comparison of DR. REDDY S LABORATORIES (DRREDDY) and MANKIND PHARMA LIMITED (MANKIND) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, DR. REDDY S LABORATORIES leads DRREDDY vs MANKIND on 7 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation40
- Profitability03
- Growth02
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
DRREDDY takes 4/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
MANKIND takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
MANKIND takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
DRREDDY takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company's working capital requirements have reduced from 85.1 days to 67.8 days"]
- − ["Dividend payout has been low at 13.2% of profits over last 3 years"]
- + ["Company has reduced debt."]
- − ["Promoter holding has decreased over last 3 years: -3.87%"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.